Comparison of Dental Benzodiazepine Prescriptions From the U.S., England, and Australia From 2013 to 2018.
Journal
American journal of preventive medicine
ISSN: 1873-2607
Titre abrégé: Am J Prev Med
Pays: Netherlands
ID NLM: 8704773
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
received:
21
10
2020
revised:
16
01
2021
accepted:
18
01
2021
pubmed:
30
3
2021
medline:
29
6
2021
entrez:
29
3
2021
Statut:
ppublish
Résumé
Benzodiazepines contribute to substance use disorder and are often part of polydrug abuse, most frequently with opioids. Although dental opioid prescribing differs significantly between countries, little is known about the patterns of dental benzodiazepine prescribing. The aim of this study is to compare dental prescribing of benzodiazepines among the U.S., England, and Australia in 2013-2018. Population-level data were accessed from national data sets for each country for dental benzodiazepine prescriptions. Outcome measures of dental benzodiazepine prescribing included: (1) prescribing rates by population for each year and (2) the quantity and relative proportion of benzodiazepines by type for each country. The analysis was conducted in 2020. Between 2013 and 2018, U.S. dentists prescribed 23 times more than English dentists and 7 times more than Australian dentists by population. During the study period, the rate of dental benzodiazepine prescribing decreased in England and the U.S. but increased in Australia. Despite these trends, U.S. dental prescribing rates remained 28 times more than English dentists and 6 times more than Australian dentists in 2018 (U.S., 3.10 prescriptions/1,000 population; England, 0.11 prescriptions/1,000 population; Australia, 0.50 prescriptions/1,000 population). U.S. dentists prescribed a wider variety of benzodiazepines than English and Australian dentists. Diazepam was most commonly prescribed in all countries. In the U.S., triazolam, lorazepam, and alprazolam were next most commonly prescribed. Temazepam was next most frequent in England and Australia. Significant variation in benzodiazepine prescribing rates and types were seen among the countries. To improve patient safety, further investigation into the appropriate use and choices of benzodiazepines in dentistry is needed.
Identifiants
pubmed: 33775512
pii: S0749-3797(21)00125-2
doi: 10.1016/j.amepre.2021.01.025
pmc: PMC8542255
mid: NIHMS1741302
pii:
doi:
Substances chimiques
Analgesics, Opioid
0
Benzodiazepines
12794-10-4
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
73-79Subventions
Organisme : AHRQ HHS
ID : R01 HS025177
Pays : United States
Informations de copyright
Copyright © 2021 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.
Références
J Dent Educ. 2001 Dec;65(12):1348-56
pubmed: 11780653
Anesth Prog. 2019 Summer;66(2):77-86
pubmed: 31184940
Clin Toxicol (Phila). 2018 Nov;56(11):1107-1114
pubmed: 29609498
Clin Toxicol (Phila). 2020 Jul;58(7):725-731
pubmed: 31612741
Clin J Pain. 2011 Mar-Apr;27(3):268-74
pubmed: 21178593
Am J Public Health. 2016 Apr;106(4):686-8
pubmed: 26890165
Br Dent J. 2005 Apr 23;198(8):489-93; discussion 483
pubmed: 15849587
Aust Dent J. 2018 Apr 19;:
pubmed: 29676050
Dent Clin North Am. 2002 Oct;46(4):767-80
pubmed: 12436831
BMC Oral Health. 2018 Oct 26;18(1):176
pubmed: 30367654
JAMA Netw Open. 2019 May 3;2(5):e194303
pubmed: 31125102
Neurosci Biobehav Rev. 1993 Fall;17(3):277-85
pubmed: 7903805
N S W Public Health Bull. 2009 Mar-Apr;20(3-4):52-5
pubmed: 19401069
Sci Rep. 2020 May 21;10(1):8463
pubmed: 32439950
Clin Oral Investig. 2018 Jun;22(5):1893-1905
pubmed: 29696421
Am Fam Physician. 2000 Apr 1;61(7):2121-8
pubmed: 10779253
Br Dent J. 2019 Sep;227(6):497-502
pubmed: 31562450
BMC Oral Health. 2019 Aug 22;19(1):193
pubmed: 31438922
J Addict Med. 2018 Jan/Feb;12(1):4-10
pubmed: 28777203